How ecstasy and psilocybin are shaking up psychiatry
Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
Source: Nature
Post-Traumatic Stress Disorder Treatment with Psychedelic Drugs
Objectives of this learning scenario, developed by NYU Langone’s High School Bioethics Project, are to understand post-traumatic stress disorder (PTSD) and the symptoms it causes, learn how the chemical psilocybin, found in psychedelic drugs, can potentially help people who have PTSD, and discuss the ethical implications of using drugs that are often used recreationally as therapeutics.
Source: NYU Med
Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac
Psilocybin, the active ingredient in ‘magic mushrooms,’ is now undergoing clinical trials. If all goes well, treatments could be available by 2024.
Source: Newsweek